Date of changeSharesDirector/
Substantial Shareholder
05 Aug 2020Acquired
800,000
Mr Kan Yow Kheong
05 Aug 2020Acquired
80,000
Mr Kan Yow Kheong
05 Aug 2020Acquired
800,000
Mr Kan Yow Kheong
05 Aug 2020Acquired
80,000
Mr Kan Yow Kheong
30 Sep 2019Acquired
217,000
Mr Kan Yow Kheong
30 Sep 2019Acquired
17,000
Mr Kan Yow Kheong
30 Sep 2019Acquired
200,000
Mr Kan Yow Kheong
09 Aug 2019Acquired
25,000
Mr Kan Yow Kheong
09 Aug 2019Acquired
10,000
Mr Kan Yow Kheong
09 Aug 2019Acquired
35,000
Kan Yow Kheong
12345


Date Title
06 Aug 2020 Changes in Director's Interest (Section 219 of CA 2016) - MR KAN YOW KHEONG
06 Aug 2020 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR KAN YOW KHEONG
13 Jul 2020 Notice of SBB by a Company Pursuant to Section 127 (16) of CA 2016
03 Jul 2020 Immediate Announcement on Shares Buy Back
29 Jun 2020 Quarterly rpt on consolidated results for the financial period ended 30/04/2020
25 Jun 2020 OTHERS
24 Mar 2020 Quarterly rpt on consolidated results for the financial period ended 31/01/2020
13 Mar 2020 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
13 Mar 2020 OTHERS
10 Mar 2020 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS


24 Jul DNeX, Pharma, AEM, Analabs, BLDplnt, EG, Gocean, HSPlant, Ikhmas, KMLoong,...
28 Nov Foundpac, Pinehill, Hua Yang, Protasco, Yong Tai, Analabs, DBE, Bright
05 Oct 拥5千万现金 寻投资机会 ‧ 安纳烈可从贸易战获利
01 Oct 慎选投资‧安纳烈保竞争力
12 Sep 安纳烈买马银行股权
07 Sep Analabs buys RM12.6m worth of Maybank shares for dividend, capital gains
30 Jul Analabs proposes one-for-one bonus issue
20 Dec Analabs 2Q profit halves on higher operating costs
23 Oct [Stocks With Momentum] Cuscapi, Inix, Nova MSC, Trive, Analabs, Triplc


ANNUAL REPORT 2019

ANNUAL REPORT 2018

ANNUAL REPORT 2017

ANNUAL REPORT 2016

ANNUAL REPORT 2015

ANNUAL REPORT 2014

ANNUAL REPORT 2013

ANNUAL REPORT 2012

ANNUAL REPORT 2011

ANNUAL REPORT 2010



Like
erkongseng and Schuan like this company.
X
  Stock ScreenerFREE TRIAL